Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 2,461.4 | 2,226.6 | 2,016.9 | 2,087.4 | 1,581.3 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 2,461.4 | 2,226.6 | 2,016.9 | 2,087.4 | 1,581.3 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 93.4 | 69.2 | 41.7 | 52.5 | 51.3 |
Total Income | 2,554.8 | 2,295.8 | 2,058.6 | 2,139.9 | 1,632.6 |
Total Expenditure | 1,765.9 | 1,617.3 | 1,527 | 1,526.7 | 1,145 |
PBIDT | 788.9 | 678.5 | 531.6 | 613.2 | 487.6 |
Interest | 22.3 | 29.4 | 37.5 | 30.2 | 16 |
PBDT | 766.6 | 649.1 | 494.1 | 583 | 471.6 |
Depreciation | 141.9 | 143.6 | 150.2 | 108.1 | 77.2 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 172 | 148 | 107.9 | 126.5 | 102.1 |
Deferred Tax | -39.5 | -4.8 | -5.1 | -1.9 | -4.2 |
Reported Profit After Tax | 492.2 | 362.3 | 241.1 | 350.3 | 296.5 |
Minority Interest After NP | 5.1 | 4.6 | 2.2 | 5.5 | 4.9 |
Net Profit after Minority Interest | 487.1 | 357.7 | 238.9 | 344.8 | 291.6 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 487.1 | 357.7 | 238.9 | 344.8 | 291.6 |
EPS (Unit Curr.) | 58.48 | 43.05 | 28.82 | 41.7 | 35.33 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 240 | 180 | 60 | 120 | 200 |
Equity | 83.6 | 83.5 | 83.4 | 83.3 | 83.3 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 32.05 | 30.47 | 26.35 | 29.37 | 30.83 |
PBDTM(%) | 31.14 | 29.15 | 24.49 | 27.92 | 29.82 |
PATM(%) | 19.99 | 16.27 | 11.95 | 16.78 | 18.75 |
Dr Lal PathLabs declared a fourth interim dividend of ₹6 per share for 2025, reflecting its strong cash generation and shareholder remittance focus.
The company declared a third interim dividend of ₹6 per share (60% on a face value of ₹10) for FY25.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.